These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Plasma lipid fractions during bopindolol treatment in hypertensive patients.
    Author: van Brummelen P, Bolli P, Koolen MI, Staehelin HB, Bühler FR.
    Journal: J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S42-4. PubMed ID: 2439818.
    Abstract:
    The influence of bopindolol monotherapy on blood pressure and plasma lipid fractions was investigated in 24 hypertensive patients. Bopindolol lowered blood pressure and heart rate significantly. When compared with placebo, no changes were found in the plasma concentrations of total cholesterol, low-density lipoprotein (LDL) cholesterol, and high-density lipoprotein (HDL) cholesterol. Plasma triglycerides were significantly increased after 4 and 8 weeks but not after 12 weeks of bopindolol. It is concluded that bopindolol is an effective and well tolerated beta blocker in hypertensive patients. That it does not lower HDL cholesterol could be a potential advantage.
    [Abstract] [Full Text] [Related] [New Search]